haloperidol and cannabidiol

haloperidol has been researched along with cannabidiol in 9 studies

Research

Studies (9)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (11.11)18.2507
2000's2 (22.22)29.6817
2010's4 (44.44)24.3611
2020's2 (22.22)2.80

Authors

AuthorsStudies
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A1
Guimarães, FS; Mechoulam, R; Morais, SL; Zuardi, AW1
Del Bel, EA; Guimarães, FS; Guimarães, VM; Zuardi, AW1
Guimarães, FS; Moreira, FA1
Del Bel, EA; Gomes, FV; Guimaraes, FS; Sonego, AB1
Aymerich, MS; Celorrio, M; Estella-Hermoso de Mendoza, A; Fernández-Suárez, D; Franco, R; Müller, CE; Oyarzábal, J; Ramírez, MJ; Rojo-Bustamante, E; Sáez, E1
Cunha, TM; Del Bel, EA; Guimarães, FS; Prado, DS; Raisman-Vozari, R; Sepulveda-Diaz, JE; Sonego, AB; Tirapelli, CR; Vale, GT1
Babinska, Z; Bucolo, C; D'Addario, C; Di Bartolomeo, M; Di Marco, R; Di Marzo, V; Drago, F; Drazanova, E; Fedotova, J; Giurdanella, G; Iannotti, FA; Kratka, L; Mechoulam, R; Micale, V; Pekarik, V; Piscitelli, F; Platania, CBM; Ruda-Kucerova, J; Salomone, S; Starcuk, Z; Stark, T; Sulcova, A; Wotjak, CT1
Guimarães, FS; Prado, DDS; Sonego, AB1

Other Studies

9 other study(ies) available for haloperidol and cannabidiol

ArticleYear
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
    Chemical research in toxicology, 2010, Volume: 23, Issue:1

    Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship

2010
Antipsychotic effect of cannabidiol.
    The Journal of clinical psychiatry, 1995, Volume: 56, Issue:10

    Topics: Adult; Cannabidiol; Diazepam; Drug Therapy, Combination; Female; Haloperidol; Humans; Psychiatric Status Rating Scales; Schizophrenia; Schizophrenic Psychology

1995
Cannabidiol increases Fos expression in the nucleus accumbens but not in the dorsal striatum.
    Life sciences, 2004, Jun-18, Volume: 75, Issue:5

    Topics: Animals; Cannabidiol; Clozapine; Haloperidol; Injections, Intraperitoneal; Male; Neostriatum; Nucleus Accumbens; Proto-Oncogene Proteins c-fos; Rats; Rats, Wistar

2004
Cannabidiol inhibits the hyperlocomotion induced by psychotomimetic drugs in mice.
    European journal of pharmacology, 2005, Apr-11, Volume: 512, Issue:2-3

    Topics: Analysis of Variance; Animals; Antipsychotic Agents; Behavior, Animal; Cannabidiol; Clozapine; Dextroamphetamine; Haloperidol; Injections, Intraperitoneal; Ketamine; Locomotion; Male; Mice; Sympathomimetics; Time Factors

2005
Cannabidiol attenuates haloperidol-induced catalepsy and c-Fos protein expression in the dorsolateral striatum via 5-HT1A receptors in mice.
    Behavioural brain research, 2016, 08-01, Volume: 309

    Topics: Animals; Antipsychotic Agents; Cannabidiol; Catalepsy; Corpus Striatum; Dopamine Antagonists; Haloperidol; Male; Mice; Neuromuscular Agents; Piperazines; Proto-Oncogene Proteins c-fos; Pyridines; Receptor, Serotonin, 5-HT1A; Serotonin Agents; Synaptic Transmission; Time Factors

2016
GPR55: A therapeutic target for Parkinson's disease?
    Neuropharmacology, 2017, Volume: 125

    Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 3,4-Dihydroxyphenylacetic Acid; Animals; Antiparkinson Agents; Basal Ganglia; Calcium-Binding Proteins; Cannabidiol; Cannabinoid Receptor Agonists; Catalepsy; Corpus Striatum; Dopamine; Haloperidol; Homovanillic Acid; Male; Mice, Inbred C57BL; Microfilament Proteins; Neurons; Parkinsonian Disorders; Receptors, Cannabinoid; RNA, Messenger

2017
Cannabidiol prevents haloperidol-induced vacuos chewing movements and inflammatory changes in mice via PPARγ receptors.
    Brain, behavior, and immunity, 2018, Volume: 74

    Topics: Animals; Antioxidants; Antipsychotic Agents; Behavior, Animal; Brain; Cannabidiol; Corpus Striatum; Dyskinesia, Drug-Induced; Dyskinesias; Female; Haloperidol; Inflammation; Male; Mastication; Mice; Mice, Inbred C57BL; Microglia; Motor Activity; Oxidative Stress; PPAR gamma; Primary Cell Culture; Superoxide Dismutase; Tardive Dyskinesia

2018
Altered dopamine D3 receptor gene expression in MAM model of schizophrenia is reversed by peripubertal cannabidiol treatment.
    Biochemical pharmacology, 2020, Volume: 177

    Topics: Animals; Antipsychotic Agents; Brain; Cannabidiol; Cerebrovascular Circulation; Disease Models, Animal; Female; Gene Expression Regulation; Haloperidol; Magnetic Resonance Imaging; Male; Methylazoxymethanol Acetate; Models, Molecular; Molecular Dynamics Simulation; Pregnancy; Prenatal Exposure Delayed Effects; Puberty; Rats, Sprague-Dawley; Receptors, Dopamine D2; Receptors, Dopamine D3; Schizophrenia

2020
PPARγ receptors are involved in the effects of cannabidiol on orofacial dyskinesia and cognitive dysfunction induced by typical antipsychotic in mice.
    Progress in neuro-psychopharmacology & biological psychiatry, 2021, 12-20, Volume: 111

    Topics: Animals; Anti-Dyskinesia Agents; Antipsychotic Agents; Behavior, Animal; Cannabidiol; Cognitive Dysfunction; Corpus Striatum; Dyskinesias; Haloperidol; Male; Mastication; Mice; Neostriatum; PPAR gamma; Rats; Rats, Wistar; Tardive Dyskinesia

2021